1 ml semaglutide GLP-1s Losing weight and keeping it off can lessen the many health risks that come with obesity GLP-1 | Semaglutide for Weight

New England Journal of Medicine , 384(11), 989-1002

(October 2014)

Among those reporting on their satisfaction with weight loss, over 50 % of participants in the retatrutide 1 mg group (n = 7

Cardiovascular Effects GLP-1 analogs are gaining interest for their cardiovascular effects beyond glucose or body weight control, as both central and peripheral activation of GLP-1 receptors has a range of impacts on heart rate (HR) and blood pressure (28, 128)

January 2026: Now that the JPML has approved centralization of Wegovy and other GLP-1 NAION (vision loss) lawsuits, the Judge overseeing the litigation is likely preparing for the first stages of the MDL

Type 2 diabetes (though it's not yet approved for this use) : In the phase 3 ACHIEVE-1 trial, adults with early type 2 diabetes who took orforglipron experienced a drop in their A1C from 8% to 6.5%6.7% after 40 weeks